Role of closure of patent foramen ovale in cryptogenic stroke: Current status

Area of Science:

• Cardiology
• Neurology
• Vascular Medicine

Background:

• Ischemic stroke is a major cause of death and disability.
• Cryptogenic stroke, where the cause is unknown, accounts for 20%-40% of cases.
• Paradoxical embolism through cardiac defects like patent foramen ovale (PFO) is a key cause of cryptogenic stroke.

Purpose of the Study:

• To evaluate the efficacy of percutaneous closure of PFO in preventing secondary strokes.
• To compare device closure with medical management for secondary stroke prevention in PFO patients.

Main Methods:

• Review of randomized trials comparing PFO device closure with medical management.
• Analysis of safety and benefit data for percutaneous closure devices.

Main Results:

• Patent foramen ovale (PFO) is found in approximately 25% of the population and is more common in cryptogenic stroke patients.
• Percutaneous closure of PFO using devices is a safe and beneficial secondary prevention strategy.
• Randomized trials demonstrate that device closure is superior to medical management for secondary stroke prevention in cryptogenic stroke patients with PFO.

Conclusions:

• Percutaneous PFO closure is a highly effective treatment for secondary stroke prevention in selected patients.
• Device closure offers a superior alternative to medical management for patients with cryptogenic stroke due to PFO.